Publications by authors named "Matthew Fury"

Claim this Profile
R
Randomized clinical efficacy and safety study of peltopepimut-S plus cemiplimab compared to cemiplimab alone in patients with recurrent/metastatic HPV16-positive head and neck cancer.
Caroline Even, Kevin J Harrington, Erminia Massarelli, Simon Laban, Jérôme Fayette, Matthew G Fury

J Immunother Cancer· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant Cemiplimab or Placebo in High-Risk Cutaneous Squamous-Cell Carcinoma.
Danny Rischin, Sandro Porceddu, Fiona Day, Daniel P Brungs, Hayden Christie, Matthew G Fury

N Engl J Med· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comparison of throwing arm kinetics and ball velocity in professional baseball pitchers with the fastest maximum joint and segment velocities.
Joseph E Manzi, Matthew Fury, Brittany Dowling, Jennifer Estrada, Kathryn McElheny

J Shoulder Elbow Surg· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cemiplimab plus peltopepimut-S vaccine in recurrent cervical cancer: A phase 2 clinical trial.
Domenica Lorusso, Ana Oaknin, Giuliano S Borges, Fernanda Damian, Nelleke Ottevanger, Matthew G Fury

Gynecol Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ethical Application of Generative Artificial Intelligence in Medicine.
Sayyida S Hasan, Matthew S Fury, Joshua J Woo, Kyle N Kunze, Prem N Ramkumar

Arthroscopy· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Effect of Concavity Restoration on Glenohumeral Stability in a Glenoid Bone Loss Model: Comparing Distal Tibial Allograft Reconstruction to Classic Latarjet.
Matthew S Fury, Carl M Cirino, Amirhossein Jahandar, Ryan C Rauck, Lawrence V Gulotta

Am J Sports Med· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increasing pitch count is associated with increasing elbow flexion angle at ball release in youth baseball pitchers.
Robert A Cecere, Matthew S Fury, Naya R Lipkens, Anna B Williams, Nathan E Matzko

J Shoulder Elbow Surg· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cemiplimab in recurrent cervical cancer: Final analysis of overall survival in the phase III EMPOWER-Cervical 1/GOG-3016/ENGOT-cx9 trial.
Ana Oaknin, Bradley J Monk, Andreia Cristina de Melo, Hee Seung Kim, Yong Man Kim, Matthew G Fury

Eur J Cancer· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2 open-label study of cemiplimab in patients with advanced cutaneous squamous cell carcinoma (EMPOWER-CSCC-1): Final long-term analysis of groups 1, 2, and 3, and primary analysis of fixed-dose treatment group 6.
Brett G M Hughes, Alexander Guminski, Samantha Bowyer, Michael R Migden, Chrysalyne D Schmults, Matthew G Fury

J Am Acad Dermatol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Patient-Relevant Measurement Strategy to Assess Clinical Benefit of Novel Therapies for Non-metastatic Cutaneous Squamous Cell Carcinoma.
Diana Rofail, Anna Ciesluk, Teya Lovell, Patrick Marquis, Matthew G Fury

Oncol Ther· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant vidutolimod and nivolumab in high-risk resectable melanoma: A prospective phase II trial.
Diwakar Davar, Robert M Morrison, Amiran K Dzutsev, Arivarasan Karunamurthy, Joe-Marc Chauvin, Matthew G Fury

Cancer Cell· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of life in cemiplimab-treated patients with locally advanced basal cell carcinoma in a Phase II clinical trial.
Alexander J Stratigos, Chieh-I Chen, Cristina Ivanescu, Karl D Lewis, Ketty Peris, Matthew G Fury

Future Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cemiplimab monotherapy in Japanese patients with recurrent or metastatic cervical cancer.
Kosei Hasegawa, Shunji Takahashi, Kimio Ushijima, Masao Okadome, Kan Yonemori, Matthew G Fury

Cancer Med· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I Study of Fianlimab, a Human Lymphocyte Activation Gene-3 (LAG-3) Monoclonal Antibody, in Combination With Cemiplimab in Advanced Melanoma.
Omid Hamid, Karl D Lewis, Amy Weise, Meredith McKean, Kyriakos P Papadopoulos, Matthew G Fury

J Clin Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality of life in patients with metastatic basal cell carcinoma treated with cemiplimab: Analysis of a phase 2 trial.
Ketty Peris, Timothy J Inocencio, Alexander J Stratigos, Karl D Lewis, Zeynep Eroglu, Matthew G Fury

Cancer Med· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Treatment Patterns and Outcomes of Cemiplimab in Patients with Advanced Cutaneous Squamous Cell Carcinoma Treated in US Oncology Practices.
Wenzhen Ge, Ning Wu, Chieh-I Chen, Timothy J Inocencio, Patrick R LaFontaine, Matthew Fury

Cancer Manag Res· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomechanical Characteristics of Ulnar Collateral Ligament Injuries Treated With and Without Augmentation: A Network Meta-analysis of Controlled Laboratory Studies.
Kyle N Kunze, Matthew S Fury, Ayoosh Pareek, Christopher L Camp, David W Altchek

Am J Sports Med· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Society for Immunotherapy of Cancer (SITC) recommendations on intratumoral immunotherapy clinical trials (IICT): from premalignant to metastatic disease.
Jason J Luke, Diwakar Davar, Robert H Andtbacka, Nina Bhardwaj, Joshua D Brody, Matthew Fury

J Immunother Cancer· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High response rate with extended dosing of cemiplimab in advanced cutaneous squamous cell carcinoma.
Danny Rischin, Brett G M Hughes, Nicole Basset-Séguin, Dirk Schadendorf, Samantha Bowyer, Matthew G Fury

J Immunother Cancer· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Differences in Patellar Height After Patellar Stabilization Procedures Not Intended to Address Patella Alta: A Multicenter Study.
R Timothy Kreulen, Gregory Anderson, Sercan Yalcin, Joseph M Hart, Kaitlyn Shank, Matthew S Fury

Orthop J Sports Med· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2 open-label, multicenter, single-arm study of cemiplimab in patients with locally advanced basal cell carcinoma after hedgehog inhibitor therapy: Extended follow-up.
Alexander J Stratigos, Aleksandar Sekulic, Ketty Peris, Oliver Bechter, Sorilla Prey, Matthew G Fury

J Am Acad Dermatol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant cemiplimab and surgery for stage II-IV cutaneous squamous-cell carcinoma: follow-up and survival outcomes of a single-arm, multicentre, phase 2 study.
Neil D Gross, David M Miller, Nikhil I Khushalani, Vasu Divi, Emily S Ruiz, Matthew G Fury

Lancet Oncol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to letter to editor on the article: Ge W, Chen C, Wu N Hedgehog pathway inhibitor real-world treatment patterns in patients with basal cell carcinoma: a claims-based analysis. 18(23), 2561-2572 (2022).
Wenzhen Ge, Chieh Chen, Ning Wu, Matthew G Fury, Emily Ruiz

Future Oncol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rice-Body Synovitis, Foreign Body Reaction, and Rotator Cuff Failure After Subacromial Balloon Spacer Augmentation of a Rotator Cuff Repair: A Case Report.
Matthew S Fury, Carl M Cirino, Alex E White, Thomas W Bauer, Samuel A Taylor

JBJS Case Connect· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation, Treatment, and Outcomes of Batter's Shoulder.
Matthew S Fury, Laura K Moore, Tyler D DeSena, Christopher L Camp, Joshua S Dines

Curr Rev Musculoskelet Med· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis